Blog - Page 2420 of 5624

TuesdayApr 11, 2017 2:15 pm

One Step Vending Corp. (KOSK) is “One to Watch”

One Step Vending Corp. (OTC: KOSK) is focused on growing through acquisitions and cooperative agreements with companies that have potential and capabilities of achieving sustainable growth and rapidly capturing market share. The company provides financing and operational business support while also helping build key growth strategies. Key business sectors actively targeted include food and refreshment services, self-checkout systems and mobile vending machines. Corporate Refreshment Services (CRS) Micro Markets Inc., a subsidiary of One Step Vending, is a self-checkout retailer that offers a wide range of food and beverages. Regardless if a traditional vending machine or the high-tech micro market is…

TuesdayApr 11, 2017 1:49 pm

eXp World Holdings, Inc. (EXPI) Using the Internet to Complement Real Estate Agents, Not Replace Them

Most businesses across numerous industries would agree that the internet has disrupted them in one way or another, either positively or negatively. Some believe the internet has led to technological advancements never seen before that have enabled them to cut costs, keep their information safe, and make certain day-to-day tasks easier. Others have seen the internet lead to an increase in unemployment, more space for security breaches, and a lack of human touch when it comes to interactions with consumers. But how has the proliferation of the internet disrupted those in the real estate industry? Recent studies (http://dtn.fm/0wF0F) show that…

TuesdayApr 11, 2017 12:21 pm

The Value Drivers of InMed Pharmaceuticals Inc. (IMLFF)

The cannabis plant is comprised of, among other things, phytochemicals that have evolved over time to become very biologically active. Most of the current research and development (R&D) surrounding cannabis revolves around understanding these biologically-active ingredients, especially cannabinoids. To date, over 90 cannabinoids have been isolated from cannabis, each affecting the body’s cannabinoid receptors and responsible for distinctive pharmacological effects. The cannabinoids that bind more selectively to certain receptors have become more desirable for medical usage because of the advantage offered. Examples of phytochemicals that have been developed into pharmaceutical drugs include the bronchodilator (asthma), salicin (aspirin) and a number…

TuesdayApr 11, 2017 9:08 am

Grey Cloak Tech, Inc. (GRCK) is “One to Watch”

Grey Cloak Tech, Inc. (OTC: GRCK) is a developer of industry-leading click-fraud detection software designed to overcome the most expensive and devastating threats in the digital world. Through its recently acquired subsidiary, ShareRails, Grey Cloak now also provides sophisticated e-commerce tools that help retailers evolve beyond their brick-and-mortar business practices to increase both their digital engagement and their foot traffic. ShareRails is an online-to-offline technology firm that provides vitally important services within the trillion-dollar retail sector, helping brick-and-mortar retailers compete directly for online awareness with e-commerce-only brands. Through the ShareRails O2O platform, offline retailers can use online channels to more…

MondayApr 10, 2017 1:25 pm

CD International Enterprises, Inc. (CDII) Announces Engagement of QualityStocks Corporate Communications Suite

CD International Enterprises, Inc. (OTC: CDII), a U.S.-based company that sources industrial commodities and provides business and management corporate consulting services, today announced that it has engaged the Corporate Communications Services of QualityStocks. "As a growing international brand, we want to maintain communication with our shareholders while increasing our online visibility and attracting new investors," Dr. James Wang, chairman and CEO of CD International, stated in a news release. "We are excited to work with QualityStocks to achieve these communication goals and look forward to utilizing their expertise in this area." Under the agreement, QualityStocks will leverage its network of…

MondayApr 10, 2017 9:13 am

InMed Pharmaceuticals, Inc. (IMLFF) Offers More than Just a Non-THC Cannabinoid Drug Pipeline

Now that 28 states have passed comprehensive medical marijuana laws, conditions have never looked better for expanding research and development (R&D) into the therapeutic benefits of cannabinoids, which is exactly what InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) is doing. Its efforts have already borne results: the company has two novel drug candidates in its pipeline. But there’s more to InMed than meets the eye; the Vancouver, Canada-based company has developed a proprietary process to manufacture cannabinoids based on biosynthesis. In addition, it has constructed an algorithm to identify the cannabinoids most likely to have beneficial therapeutic effect. With this…

FridayApr 07, 2017 12:27 pm

Player’s Network, Inc. (PNTV) – Using Unique Business Models to Increase Revenue

Player’s Network, Inc. (OTCQB: PNTV) is a fully reporting diversified holdings company, operating in two main industries: medical marijuana and media. The company’s primary objective is to create shareholder value by identifying opportunities in niche emerging markets. PNTV has three prominent subsidiaries: Next Gen TV, WeedTV.com, and Green Leaf Farms, all of which operate under profitable business models. The primary goal for WeedTV.com is to generate revenues from its proprietary channels and clients. Proprietary channels that Player’s Network is able to generate revenues through include membership subscriptions, advertising, and cross-selling with other organizations. In addition to this, the company’s Next…

FridayApr 07, 2017 12:11 pm

Marina Biotech, Inc. (MRNA) Sets Further Development of Drug Candidates IT-102 and IT-103, Signs Windlas Healthcare Manufacturing Agreement

Marina Biotech Inc. (OTCQB: MRNA) filed a 10K with the SEC on April 5, 2017, for its year ended December 31, 2016. The late stage biopharmaceutical company summarized its achievements in 2016 and provided an outlook into its 2017 performance, including its planned clinical trials in 2018. Marina Biotech specializes in creating and commercializing innovative therapies for treatments of cancer, hypertension, and arthritis. The firm plans to move by the first quarter of 2018 into a phase 3 clinical study of its drug candidate, IT-102, a fixed dose combination (FDC) bi-layer tablet, said Joseph Ramelli, chief executive officer of Marina…

FridayApr 07, 2017 9:20 am

India Globalization Capital, Inc. (NYSE: IGC) at the Forefront of Innovation Thanks to Strategic Alliances

How does a company in the mining industry successfully move toward becoming a leader in the marijuana sector, specifically cannabinoid-based pharmaceutical therapies that treat a variety of diseases and conditions? In the case of India Globalization Capital, Inc. (NYSE MKT: IGC), the answer is creative management’s ability to identify opportunity, coupled with a relentless drive toward innovation. IGC made its switch to the marijuana industry after its CEO, Executive Chairman, and President Ram Mukunda was unafraid to recognize and act on a need for the company to make a positive and swift switch to a stronger and more lucrative market.…

ThursdayApr 06, 2017 1:01 pm

InMed Pharmaceuticals, Inc. (IMLFF) Adds to Its Drug Development Pipeline

A pre-clinical stage biopharmaceutical company, InMed Pharmaceuticals, Inc. (OTCQB: IMLFF) has revealed two additions to its drug development pipeline. An expedited drug development timeline is now in place for INM-750 for epidermolysis bullosa (EB), with a potential market of about $1 billion. The disease is characterized by fragile skin in children. The company has also announced the development of INM-085 for glaucoma, which represents a potential global market of over $5 billion. Resulting in a defect in the connective tissue between the dermis and epidermis, most often caused by a lack of keratins, EB currently has no medication-based treatments. Multiple…

Site Search

Company Search